Chi‐square analysis revealed that miR‐145‐5p levels had little correlation with patients' age, gender, BRAF mutation but were significantly associated with tumor thickness, NRAS mutation, and tumor stage (P < 0.05). The gene discussed is BRAF; the disease is neoplasm.